SAFETY AND PHARMACOKINETICS OF MIFENTIDINE AFTER INCREASING ORAL DOSES IN HEALTHY-SUBJECTS

被引：1
作者：
IMBIMBO, BP
SEIBERLING, M
PEUCKERT, U
HOEXTER, G
MAIERLENZ, H
VIDI, A
DANIOTTI, S
机构：
[1] BOEHRINGER INGELHEIM,MILAN,ITALY
[2] INST CLIN PHARMACOL,FREIBURG,FED REP GER
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 06期
关键词：
D O I：
10.1007/BF00637606
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：673 / 676
页数：4
相关论文
共 50 条
  • [31] Entecavir pharmacokinetics, safety, and tolerability after multiple ascending doses in healthy subjects
    Yan, Jing-He
    Bifano, Marc
    Olsen, Steven
    Smith, Robert A.
    Zhang, Duxi
    Grasela, Dennis M.
    LaCreta, Frank
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (11) : 1250 - 1258
  • [32] PHARMACOKINETICS OF MECILLINAM IN HEALTHY-SUBJECTS
    GAMBERTOGLIO, JG
    BARRIERE, SL
    LIN, ET
    CONTE, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (06) : 952 - 956
  • [33] PHARMACOKINETICS OF ORAL [C-14] SULMAZOL IN HEALTHY-SUBJECTS
    HALLINAN, D
    LAMBE, R
    DARRAGH, A
    ROTH, W
    KOSS, FW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (01) : P112 - P113
  • [34] Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects
    Iwamoto, M.
    Wenning, L. A.
    Petry, A. S.
    Laethem, M.
    De Smet, M.
    Kost, J. T.
    Merschman, S. A.
    Strohmaier, K. M.
    Ramael, S.
    Lasseter, K. C.
    Stone, J. A.
    Gottesdiener, K. M.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (02) : 293 - 299
  • [35] Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects
    Erhardtsen, E
    Nilsson, P
    Johannessen, M
    Thomsen, MS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (08) : 880 - 885
  • [36] PHARMACOKINETICS OF METAMIZOL METABOLITES IN HEALTHY-SUBJECTS AFTER A SINGLE ORAL DOSE OF METAMIZOL SODIUM
    VLAHOV, V
    BADIAN, M
    VERHO, M
    BACRACHEVA, N
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (01) : 61 - 65
  • [37] SAFETY, TOLERANCE AND PHARMACOKINETICS OF CEFPIROME ADMINISTERED INTRAMUSCULARLY TO HEALTHY-SUBJECTS
    MEYER, BH
    MULLER, FO
    LUUS, HG
    DREES, B
    ROTHIG, HJ
    BADIAN, M
    ECKERT, HG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 : 63 - 70
  • [38] PHARMACOKINETICS OF RILMENIDINE IN HEALTHY-SUBJECTS
    GENISSEL, P
    BROMET, N
    FOURTILLAN, JB
    MIGNOT, A
    ALBIN, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (07) : D47 - D53
  • [39] PHARMACOKINETICS OF AZLOCILLIN IN HEALTHY-SUBJECTS
    LEROY, A
    HUMBERT, G
    FILLASTRE, JP
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1981, : 49 - 54
  • [40] SAFETY, TOLERANCE, AND PHARMACOKINETICS OF CEFEPIME ADMINISTERED INTRAMUSCULARLY TO HEALTHY-SUBJECTS
    BARBHAIYA, RH
    KNUPP, CA
    TENNEY, J
    MARTIN, RR
    WEIDLER, DJ
    PITTMAN, KA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10) : 900 - 910
12345